BUPIVACAINE HCI 2.5 mg/mL
BUPIVACAINE HCI · INJECTION, SOLUTION · HF Acquisition Co LLC, DBA HealthFirst
No Recall HistoryCurrently in Shortage
Plain English
BUPIVACAINE HCI is a injection, solution containing bupivacaine hci at 2.5 mg/mL, taken infiltration. Manufactured by HF Acquisition Co LLC, DBA HealthFirst.
Key Facts
- Brand Name
- BUPIVACAINE HCI
- Generic Name
- BUPIVACAINE HCI
- NDC Code (Product)
51662-1581- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Strength
- 2.5 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INFILTRATION, PERINEURAL
- Marketing Status
- Application #
- ANDA207183
- Marketing Start
- 07/10/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is BUPIVACAINE HCI used for?
BUPIVACAINE HCI contains BUPIVACAINE HCI. It is a injection, solution taken infiltration. Consult your doctor for specific uses.
Is BUPIVACAINE HCI a controlled substance?
BUPIVACAINE HCI is not classified as a controlled substance by the DEA.
What is the generic name for BUPIVACAINE HCI?
The generic name for BUPIVACAINE HCI is BUPIVACAINE HCI. There are 1 other brand versions of BUPIVACAINE HCI.
What is the NDC code for BUPIVACAINE HCI 2.5 mg/mL?
The NDC (National Drug Code) for BUPIVACAINE HCI 2.5 mg/mL is 51662-1581, listed by HF Acquisition Co LLC, DBA HealthFirst.